The Outcomes of Arteriovenous Fistula Cannulated From Different Direction.

NCT ID: NCT01642459

Last Updated: 2015-05-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-09-30

Study Completion Date

2013-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators hypothesis that aneurysms and stenoses will be decreased if the direction of inserted arterial needle were same as the direction of blood flow, when compared to the opposite direction puncture.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Native arteriovenous fistula (AVF) is the preferred access for hemodialysis, and cannulation technique is very important factors affect the outcomes of AVF. Rope-ladder cannulation is one kind of the standard puncture techniques which is used commonly in maintenance hemodialysis (MHD) patients. There are many complications for rope-ladder cannulation, such as venous aneurysm and vascular stenosis, which may induce AVF dysfunction. For the venous outflow way, there always be aneurysm followed by stenoses at the sites of needle connected with the arterial line in rope-ladder cannulation patients. The investigators hypothesis that the directions of inserted arterial needles should affect the AVF outcomes. The present prospective study will compare the outcomes of AVF between the puncture direction at arterial needle sites same as blood flow and opposite to blood flow.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arteriovenous Fistula

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Same direction cannulation

The inserted direction of arterial needle is same as the direction of blood flow.

Group Type EXPERIMENTAL

Same direction cannulation

Intervention Type OTHER

The puncture direction of the arterial needle is same as the blood flow in every hemodialysis session.

Opposite direction cannulation

The inserted direction of arterial needle is opposite to the direction of blood flow.

Group Type ACTIVE_COMPARATOR

Opposite direction cannulation

Intervention Type OTHER

The puncture direction of the arterial needle is opposite to the blood flow in every hemodialysis session.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Same direction cannulation

The puncture direction of the arterial needle is same as the blood flow in every hemodialysis session.

Intervention Type OTHER

Opposite direction cannulation

The puncture direction of the arterial needle is opposite to the blood flow in every hemodialysis session.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* MHD patients with autogenous AVF.
* Newly setup AVF in 3 months.
* Fore- or Upper arm AVF.
* Flow of \>800ml/min detected by using the ultrasound dilution technique.

Exclusion Criteria

* AVF after neoplasty.
* Arteriovenous grafts.
* Anticipated live time less than one year.
* Patients whose concurrent illnesses, disability, or geographical residence would hamper attendance at required study visit.
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dongliang Zhang, MD

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dongliang Zhang, MD

Associated professer

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dongliang Zhang, Doctor

Role: STUDY_CHAIR

Kidney Disease Faculty of Capital Medical University

Wenying Cui, Bachelor

Role: STUDY_DIRECTOR

Nephrology Department of Beijing Friendship Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Beijing Friedship Hospital

Beijing, Beijing Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2012-0107

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Arteriovenous Vascular (AV) ACCESS Trial
NCT04646226 ACTIVE_NOT_RECRUITING NA